NuVasive develops and markets minimally invasive products and related solutions for spinal surgeries.


Updates from The Motley Fool

Latest updates on NuVasive from Fool.com.  The Fool has written over 100 articles on NuVasive.
NuVasive Sees a Stronger 2018

The spinal surgical equipment specialist saw growth flatten out but still posted its first $1 bil...



Stock Performance

View Interactive NUVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about NuVasive.
Current Price: $57.34
Prev Close: $58.59
Open: $58.40
Bid: $56.68
Ask: $60.68
Day's Range: $56.87 - $58.61
52wk Range: $43.51 - $72.41
Volume: 863,569
Avg Vol 921,878
Market Cap: $3B
P/E (ttm): 122.06
EPS (ttm): $0.48
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NuVasive.
CAPS Rating 5 out of 5
 
259 Outperform
17 Underperform
CAPS All Stars
 
77 Outperform
3 Underperform

How do you think NuVasive will perform against the market?



You pick for NuVasive is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chris Barry, CEO

62% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NuVasive.

NuVasive develops and markets minimally invasive products and related solutions for spinal surgeries.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT